New tool helps women decide on HIV prevention

NCT ID NCT05619497

Completed Prevention Sponsor: University of California, San Francisco Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested a tablet-based tool and clinic training to help women learn about HIV prevention, including PrEP. 141 women from a Florida clinic participated. The goal was to see if these tools helped women make informed choices and start prevention methods.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: decision-support tool and clinic training
What this could lead to: If successful, this approach could help more women at risk for HIV learn about and choose prevention methods that fit their lives.
What could go wrong: This is a small, completed study in one clinic, so results may not apply everywhere. It tested a process, not a new drug, so impact depends on how clinics adopt it.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HUMAN IMMUNODEFICIENCY VIRUS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

AIDS sexually transmitted disease HIV infectious disease prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HUMAN IMMUNODEFICIENCY VIRUS HUMAN IMMUNODEFICIENCY VIRUS TRANSMISSION SEXUALLY TRANSMITTED DISEASES

Contacts and locations

Locations

Florida Department of Health, Duval County

Jacksonville, Florida, 32211, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.